Literature DB >> 23007121

Vitamin D status in HIV-infected patients with and without tuberculosis: a pilot study.

Andrew P Steenhoff, Abiona Redwood, John M Pettifor, Joseph Hove, Gregory P Bisson, Mosepele Mosepele, Phillip Pusoesele, Rameshwari Thakur, Carrie Kovarik, Robert Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23007121      PMCID： PMC3462884          DOI： 10.1097/QAI.0b013e3182683cd2

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  8 in total

1.  Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.

Authors:  Philip T Liu; Steffen Stenger; Dominic H Tang; Robert L Modlin
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic.

Authors:  Francis F Fountain; Elizabeth Tolley; Cary R Chrisman; Timothy H Self
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

3.  Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism.

Authors:  S E Williams; A G Wardman; G A Taylor; M Peacock; N J Cooke
Journal:  Tubercle       Date:  1985-03

Review 4.  Vitamin D: modulator of the immune system.

Authors:  Femke Baeke; Tatiana Takiishi; Hannelie Korf; Conny Gysemans; Chantal Mathieu
Journal:  Curr Opin Pharmacol       Date:  2010-04-27       Impact factor: 5.547

5.  Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa.

Authors:  Katherine B Gibney; Lachlan MacGregor; Karin Leder; Joseph Torresi; Caroline Marshall; Peter R Ebeling; Beverley-Ann Biggs
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

6.  The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion.

Authors:  Elly Wijaya Nursyam; Zulkifli Amin; C Martin Rumende
Journal:  Acta Med Indones       Date:  2006 Jan-Mar

7.  Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response.

Authors:  Henrik Friis; Nyagosya Range; Marianne L Pedersen; Christian Mølgaard; John Changalucha; Henrik Krarup; Pascal Magnussen; Christian Søborg; Ase B Andersen
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

8.  Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.

Authors:  Somsak Akksilp; Opart Karnkawinpong; Wanpen Wattanaamornkiat; Daranee Viriyakitja; Patama Monkongdee; Walya Sitti; Dhanida Rienthong; Taweesap Siraprapasiri; Charles D Wells; Jordan W Tappero; Jay K Varma
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883
  8 in total
  6 in total

1.  High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.

Authors:  Virginia A Stallings; Joan I Schall; Mary L Hediger; Babette S Zemel; Florin Tuluc; Kelly A Dougherty; Julia L Samuel; Richard M Rutstein
Journal:  Pediatr Infect Dis J       Date:  2015-02       Impact factor: 2.129

2.  Safety and Efficacy of High-Dose Daily Vitamin D3 Supplementation in Children and Young Adults Infected With Human Immunodeficiency Virus.

Authors:  Kelly A Dougherty; Joan I Schall; Babette S Zemel; Florin Tuluc; Xiaoling Hou; Richard M Rutstein; Virginia A Stallings
Journal:  J Pediatric Infect Dis Soc       Date:  2014-03-27       Impact factor: 3.164

3.  Vitamin D Status in Botswana Children Under 2 Years Old With and Without Active Tuberculosis.

Authors:  Jonathan Ludmir; Loeto Mazhani; Mark S Cary; Unoda A Chakalisa; John M Pettifor; Mooketsi Molefi; Abiona Redwood; Virginia A Stallings; Robert Gross; Andrew P Steenhoff
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

4.  Vitamin D₃supplementation in Batswana children and adults with HIV: a pilot double blind randomized controlled trial.

Authors:  Andrew P Steenhoff; Joan I Schall; Julia Samuel; Boitshepo Seme; Marape Marape; Bakgaki Ratshaa; Irene Goercke; Michael Tolle; Maria S Nnyepi; Loeto Mazhani; Babette S Zemel; Richard M Rutstein; Virginia A Stallings
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

5.  Vitamin D deficiency and the risk of tuberculosis: a meta-analysis.

Authors:  Shao-Jun Huang; Xian-Hua Wang; Zhi-Dong Liu; Wen-Li Cao; Yi Han; Ai-Guo Ma; Shao-Fa Xu
Journal:  Drug Des Devel Ther       Date:  2016-12-28       Impact factor: 4.162

6.  Vitamin D₃ Status and the Association with Human Cathelicidin Expression in Patients with Different Clinical Forms of Active Tuberculosis.

Authors:  Senait Ashenafi; Jolanta Mazurek; Anders Rehn; Beede Lemma; Getachew Aderaye; Amsalu Bekele; Getachew Assefa; Menberework Chanyalew; Abraham Aseffa; Jan Andersson; Peter Bergman; Susanna Brighenti
Journal:  Nutrients       Date:  2018-06-04       Impact factor: 5.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.